Phytoestrogens as natural prodrugs in cancer prevention: A novel concept

Phytochemistry Reviews

Volumn 7, Issue 3, 2008, Pages 431-443

  Arroo, Randolph R J ^a   Androutsopoulos, Vasilis ^a   Patel, Asma ^a   Surichan, Somchaiya ^a   Wilsher, Nicola ^a   Potter, Gerry A ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

CYP1; Drug metabolism; Flavones; Natural products; Prevention

Indexed keywords

ALKYLATING AGENT; ANASTROZOLE; ANTIMETABOLITE; ANTIMITOTIC AGENT; APIGENIN; BICALUTAMIDE; CYTOCHROME P450 1B1; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; FLAVONE DERIVATIVE; GEFITINIB; GEMTUZUMAB OZOGAMICIN; IMATINIB; INTERCALATING AGENT; KAEMPFEROL; LETROZOLE; PACLITAXEL; PHYTOESTROGEN; PLATINUM DERIVATIVE; RESVERATROL; RETINOIC ACID; RITUXIMAB; SCUTELLAREIN; TAMOXIFEN; TRASTUZUMAB; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD CLOTTING; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARDIOTOXICITY; CELL GROWTH; COLON CANCER; CONFERENCE PAPER; CYP1 GENE; CYTOTOXICITY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; ENDOMETRIUM CANCER; FATIGUE; FEVER; FLUID RETENTION; FRUIT; GASTROINTESTINAL SYMPTOM; GENE; GENE EXPRESSION REGULATION; GENOME; GROWTH INHIBITION; HAIR LOSS; HEARING LOSS; HOT FLUSH; HUMAN; HUMAN CELL; HUMAN TISSUE; INFERTILITY; MEDICINAL PLANT; MOUSE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RASH; RESPIRATORY DISTRESS; RISK REDUCTION; SECOND CANCER; SIDE EFFECT; TISSUE DISTRIBUTION; UTERINE CERVIX CANCER; VEGETABLE; WEIGHT GAIN; WILLOW;

EID: 48449103446     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-008-9093-5     Document Type: Conference Paper

References (57)

1. R Abou-Jawde T Choueiri C Alemany T Mekhail 2003 An overview of targeted treatments in cancer Clin Ther 25 2121 2137
2. K Alexandrove I Cascorbi M Rojas G Bouvier E Kriek H Bartsch 2002 CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation Carcinogenesis 23 1969 1977
3. BN Ames 1983 Dietary carcinogens and anticarcinogens-oxygen radicals and degenerative diseases Science 221 1256 1264
4. C Atkinson CL Frankenfeld JW Lampe 2005 Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health Exp Biol Med 230 155 170
5. E Brantley S Antony G Kohlhagen LH Meng K Agama SF Stinson EA Sausville Y Pommier 2006 Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5- fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells Cancer Chemother Pharmacol 58 62 72
6. VM Breinholt EA Offord C Brouwer SE Nielsen K Brøsen Friedberg 2002 In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids Food Chem Toxicol 40 609 616
7. MD Burke RT Mayer 1974 Ethoxyresorufin-direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene Drug Metab Dispos 2 583 588
8. HY Chan LK Leung 2003 A potential protective mechanism of soya isoflavones against tumour initiation Brit J Nutr 90 457 465
9. T Chen LP Li XY Lu HD Jiang S Zeng 2007 Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract J Agri Food Chem 55 273 277
10. YJ Chun MY Kim FP Guengerich 1999 Resveratrol is a selective human cytochrome P450 1A1 inhibitor Biochem Biophys Res Comm 262 20 24
11. GM Cragg DJ Newman 2000 Antineoplastic agents from natural sources: achievements and future directions Expert Opin Investig Drugs 9 2783 2797
12. M Dietel MA Lewis S Shapiro 2005 Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review Hum Repr 20 2052 2060
13. HM Dodds PJ Tobin CF Stewart P Cheshire S Hanna P Houghton LP Rivory 2002 The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model J Pharmacol Exp Ther 303 649 655
14. C Duffy M Cyr 2003 Phytoestrogens: Potential benefits and implications for breast cancer survivors J Women Health 12 617 631
15. MS DuPont AJ Day RN Bennett FA Mellon PA Kroon 2004 Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans Eur J Clin Nutr 58 947 954
16. K Durgo L Vukovic G Rusak M Osmak JF Colic 2007 Effect of flavonoids on glutathione level, lipid peroxidation and cytochrome P450CYP1A1 expression in human laryngeal carcinoma cell lines Food Tech Biotech 45 69 79
17. I Erlund 2004 Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology Nutri Res 24 851 874
18. NR Ferrigni JL Mclaughlin RG Powell CR Smith 1984 Use of potato disk and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia-lagascae J Nat Prod 47 347 352
19. P Gibson JH Gill PA Khan JM Seargent SW Martin PA Batman J Griffith C Bradley JA Double MC Bibby PM Loadman 2003 Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: Implications for drug development Mol Cancer Ther 2 527 53
20. A Gradolatto MC Canivenc-Lavier JP Basly MH Siess C Teyssier 2004 Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver Drug Metab Dispos 32 58 65
21. B Halliwell 2000 The antioxidant paradox The Lancet 335 1179 1180
22. B Halliwell 2007 Dietary polyphenols: Good, bad, or indifferent for your health? Cardiovascular Res 73 341 347
23. Halliwell B, Rafter J, Jenner A (2005) Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr 81:268S-276S
24. P Hodek P Hanustiak J Krizkova R Mikelova S Krizkova M Stiborova L Trnkova A Horna M Beklova R Kizek 2006 Toxicological aspects of flavonoid interaction with biomacromolecules. Neuroendocrin Lett 27 2 14 17
25. MS Jang EN Cai GO Udeani KV Slowing CF Thomas CWW Beecher HHS Fong NR Farnsworth AD Kinghorn RG Mehta RC Moon JM Pezzuto 1997 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 218 220
26. M Jang JM Pezzuto 1999 Cancer chemopreventive activity of resveratrol Drug Exp Clin Res 25 65 77
27. AD Kinghorn BN Su D Lee JQ Gu JM Pezzuto 2003 Cancer chemopreventive agents discovered by activity-guided fractionation: An update Curr Org Chem 7 213 226
28. AD Kinghorn BN Su DS Jang LC Chang D Lee JQ Gu EJ Carcache-Blanco AD Powlus SK Lee EJ Park M Cuendet JJ Gills K Bhat HS Park E Mata-Greenwood LL Song MH Jong JM Pezzuto 2004 Natural inhibitors of carcinogenesis Planta Medica 70 691 705
29. S Knasmüller H Steinkellner BJ Majer EC Nobis G Scharf F Kassie 2002 Search for dietary antimutagens and anticarcinogens: methodological aspects and extrapolation problems Food Chem Toxicol 40 1051 1062
30. MJ Kuffel JC Schroeder LJ Pobst S Naylor JM Reid SH Kaufmann MM Ames 2002 Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2 Mol Pharmacol 62 143 153
31. A Kuijsten ICW Arts PCH Hollman P van't Veer E Kampman 2006 Plasma enterolignans are associated with lower colorectal adenoma risk Cancer Epidemiol Biomarkers Prev 15 1132 1136
32. C La Vecchia A Altieri A Tavani 2001 Vegetables, fruit, antioxidants and cancer: a review of Italian studies Eur J Nutr 40 261 267
33. J Lu C Ho G Ghai KJ Chen 2001 Resveratrol analogue 3,4,5,4′- tetrahydroxystilbene differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 22 321 328
34. MCE McFadyen WT Melvin GI Murray 2004 Cytochrome P450 enzymes: Novel options for cancer therapeutics Mol Cancer Ther 3 363 371
35. YJ Moon XD Wang ME Morris 2006 Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism Toxicol In Vitro 20 187 210
36. GI Murray MC Taylor MCE McFadyen JA McKay WF Greenlee MD Burke WT Melvin 1997 Tumor specific expression of cytochrome P450 CYP1B1 Cancer Res 57 3026 3031
37. GI Murray WT Melvin WF Greenlee MD Burke 2001 Regulation, function, and tissuespecific expression of cytochrome P450 CYP1B1 Annu Rev Pharmacol Toxicol 41 297 316
38. LM Pasetto C Falci A Compostella G Sinigaglia E Rossi S Monfardini 2007 Quality of life in elderly cancer patients Eur J Cancer 43 1508 1513
39. B Piver M Fer X Vitrac JM Merillon Y Dreano F Berthou D Lucas 2004 Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes Biochem Pharmacol 68 773 782
40. LJ Pobst MM Ames 2006 CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines Cancer Chemother Pharmacol 57 569 576
41. C Pohl F Will H Dietrich D Schrenk 2006 Cytochrome p450 1A1 expression and activity in Caco-2 cells: Modulation by apple juice extract and certain apple polyphenols J Agric Food Chem 54 10262 10268
42. Potter GA, Butler PC (2004) 3,4-Methylenedioxy-substituted chalcones as therapeutic agents. Patent Application Publication US2004/0254149 A1
43. GA Potter LH Patterson E Wanogho PJ Perry PC Butler T Ijaz KC Ruparelia JH Lamb PB Farmer LA Stanley MD Burke 2002 The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 Brit J Cancer 86 774 778
44. SE Rickard LJ Orcheson MM Seidl L Luyengi HHS Fong LU Thompson 1996 Dose dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed J Nutr 126 2012 2019
45. M Rooseboom JNM Commandeur NPE Vermeulen 2004 Enzyme-catalyzed activation of anticancer prodrugs Pharmacol Rev 56 53 102
46. J Russo IH Russo 2004 Genotoxicity of steroidal estrogens Trend Endocrinol Metab 15 211 214
47. S Sale RD Verschoyle D Boocock DJL Jones N Wilsher KC Ruparelia GA Potter PB Farmer WP Steward AJ Gescher 2004 Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene Brit J Cancer 90 736 744
48. K Shimoi H Okada M Furugori T Goda S Takase M Suzuki Y Hara H Yamamoto N Kinae 1998 Intestinal absorption of luteolin and luteolin 7-O-L-glucoside in rats and humans FEBS Lett 438 220 224
49. Stanley LA, Ball MT, Eaden J, Potter GA, Rolls S, Burke MD (2001a) Cytochrome P450 CYP1B1 in colon tumorigenesis. Drug Metab Rev 33(Suppl 1):62
50. Stanley LA, Ball MT, Butler PC, Hoang TTV, Potter GA & Burke MD (2001b) CYP1B1 expression in human cervical abnormalities. Drug Metab Rev 33(Suppl 1):77
51. M Suggitt C Bibby 2005 50 Years of Preclinical anticancer drug screening: Empirical to target-driven approaches Clin Cancer Res 11 971 981
52. Y Tsuchiya M Nakajima T Yokoi 2005 Cytochrome P450-mediated metabolism of estrogens and its regulation in human Cancer Lett 227 115 124
53. PA Tsuji T Walle 2006 Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids Carcinogenesis 27 1579 1585
54. T Usui 2006 Pharmaceutical prospects of phytoestrogens Endocr J 53 7 20
55. M Valko CJ Rhodes J Moncol M Izakovic M Mazur 2006 Free radicals, metals and antioxidants in oxidative stress-induced cancer Chem-Biol Interact 160 1 40
56. HG van der Poel 2004 Smart drugs in prostate cancer Eur Urol 45 1 17
57. JY Zhang Y Wang C Prakash 2006 Xenobiotic-metabolizing enzymes in human lung Curr Drug Metab 7 939 948